PEGBIO CO-B

Peger Biopharmaceuticals (Suzhou) Co., Ltd. is a biomedical company focusing on the development of innovative drugs. It was founded in Suzhou Industrial Park (BioBay) in May 2008. Based on a deep understanding of the pathogenesis of chronic diseases, treatment needs of patients with chronic diseases, and competition in the chronic disease market, the company focused on new mechanisms of action and targets with potential advantages, and independently developed drug molecules with high efficacy and good safety through the HECTORTM core technology system, covering a wide range of chronic diseases with large numbers of patients and long medication cycles, such as type 2 diabetes, non-alcoholic fatty liver disease, obesity, hyperuricemia, gout, and Alzheimer's disease, and gradually extended to other chronic diseases, including constipation caused by opioids, congenital hyperinsulemia, etc..